Erenumab Decreases Headache-Related Sick Leave Days and Health Care Visits: A Retrospective Real-World Study in Working Patients with Migraine

INTRODUCTION: The prevalence of migraine is highest among working age individuals, and this disease is associated with an increased number of sick leaves and health care visits, as well as lost productivity. Erenumab, the first monoclonal antibody targeting the calcitonin gene-related peptide (CGRP)...

Descripción completa

Detalles Bibliográficos
Autores principales: Autio, Henri, Purmonen, Timo, Kurki, Samu, Mocevic, Emina, Korolainen, Minna A., Tuominen, Samuli, Lassenius, Mariann I., Nissilä, Markku
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660656/
https://www.ncbi.nlm.nih.gov/pubmed/34888760
http://dx.doi.org/10.1007/s40120-021-00303-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660656/
https://www.ncbi.nlm.nih.gov/pubmed/34888760
http://dx.doi.org/10.1007/s40120-021-00303-x

Ejemplares similares